Where do we stand? Functional imaging in acute and chronic pulmonary embolism with state-of-the-art CT

被引:10
|
作者
Meyer, Mathias [1 ,3 ]
Haubenreisser, Holger [1 ,3 ]
Sudarski, Sonja [1 ,3 ]
Doesch, Christina [2 ,3 ]
Ong, Melissa M. [1 ]
Borggrefe, Martin [2 ,3 ]
Schoenberg, Stefan O. [1 ]
Henzler, Thomas [1 ,3 ]
机构
[1] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, D-68167 Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Med 1, D-68167 Mannheim, Germany
[3] DZHK German Ctr Cardiovasc Res Partner Site Mannh, Mannheim, Germany
关键词
Pulmonary embolism; Chronic pulmonary embolism; Computed tomography; Dual-energy; Pulmonary perfusion; Right heart failure; DUAL-ENERGY CT; RIGHT-VENTRICULAR DYSFUNCTION; MULTIDETECTOR COMPUTED-TOMOGRAPHY; PERFUSION DEFECT SCORE; BLOOD-VOLUME IMAGES; SEVERITY ASSESSMENT; ANGIOGRAPHY; LUNG; HYPERTENSION; DIAGNOSIS;
D O I
10.1016/j.ejrad.2015.09.015
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Nowadays, CT pulmonary angiography (CTPA) is the diagnostic imaging modality of choice for acute and chronic pulmonary embolism (PE) in order to assess vascular anatomy and parenchymal morphology. Over the past decade, several prognostic CTPA markers associated with an increased risk of adverse clinical events and in-hospital mortality have been evaluated, namely cardiac chamber dimensions, obstruction scores, and visualization of iodinated contrast material in the lung parenchyma by dual-energy (DE) CTPA. This article reviews the current status and potential prognostic advantages of CTPA or DE CTPA with its recent developments for accessing right ventricular dysfunction and the assessment of first pass lung perfusion with DE CTPA in the diagnosis of acute and chronic PE. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:2432 / 2437
页数:6
相关论文
共 50 条
  • [1] State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism
    Albrecht, Moritz H.
    Bickford, Matthew W.
    Nance, John W., Jr.
    Zhang, Longjiang
    De Cecco, Carlo N.
    Wichmann, Julian L.
    Vogl, Thomas J.
    Schoepf, U. Joseph
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 208 (03) : 495 - 504
  • [2] A state-of-the-art review of esophageal trauma: where do we stand?
    Plott, E.
    Jones, D.
    McDermott, D.
    Levoyer, T.
    DISEASES OF THE ESOPHAGUS, 2007, 20 (04) : 279 - 289
  • [3] CT Pulmonary Angiography in Chronic Thromboembolic Disease: Where Do We Stand?
    Swift, Andrew J.
    Rajaram, Smitha
    RADIOLOGY, 2020, 296 (02) : 430 - 431
  • [4] State-of-the-Art Imaging for the Evaluation of Pulmonary Embolism
    Roshkovan L.
    Litt H.
    Current Treatment Options in Cardiovascular Medicine, 2018, 20 (9)
  • [5] Pharmacological and interventional management of pulmonary embolism: where do we stand?
    Nagraj, Sanjana
    Li, Weijia
    Zamora, Cristian
    Barakakis, Paraschos Archontakis
    Kokkinidis, Damianos G.
    FUTURE CARDIOLOGY, 2022, 18 (03) : 191 - 206
  • [6] Submassive and massive pulmonary embolism. Where do we stand?
    Hussein, Emad A.
    ACTA PHLEBOLOGICA, 2023, 24 (03): : 83 - 84
  • [7] Computed tomography of acute pulmonary embolism: state-of-the-art
    Long Jiang Zhang
    Guang Ming Lu
    Felix G. Meinel
    Andrew D. McQuiston
    James G. Ravenel
    U. Joseph Schoepf
    European Radiology, 2015, 25 : 2547 - 2557
  • [8] Computed tomography of acute pulmonary embolism: state-of-the-art
    Zhang, Long Jiang
    Lu, Guang Ming
    Meinel, Felix G.
    McQuiston, Andrew D.
    Ravenel, James G.
    Schoepf, U. Joseph
    EUROPEAN RADIOLOGY, 2015, 25 (09) : 2547 - 2557
  • [9] Catheter-Directed Thrombolysis for Pulmonary Embolism Where Do We Stand?
    Sista, Akhilesh K.
    Kearon, Clive
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (10) : 1393 - 1395
  • [10] Osteosarcoma treatment - Where do we stand? A state of the art review
    Luetke, Anja
    Meyers, Paul A.
    Lewis, Ian
    Juergens, Heribert
    CANCER TREATMENT REVIEWS, 2014, 40 (04) : 523 - 532